Speech-Language Pathologists in Riverdale, GA Accepting Medicare

16 Speech-Language Pathologists found. Showing 1 - 16

Tushanna Purdie Cole Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Derby Dr, Riverdale, GA 30274 Phone: 770-827-0875    Fax: 678-379-0168

Brittney Moore Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8104 Webb Rd, Riverdale, GA 30274 Phone: 334-221-8183

Leah K Kendrick, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1442 Cambridge Ct, Riverdale, GA 30296 Phone: 770-997-1791

Ms. Lashawn Annette Simington-leroy, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Upper Riverdale Rd Sw, Riverdale, GA 30274 Phone: 770-991-2636

Kelley Ann Colyott, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Upper Riverdale Rd Sw, Riverdale, GA 30274 Phone: 770-991-2636

April Shannelle Carter, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6555 Professional Pl Ste A, Riverdale, GA 30274 Phone: 770-997-7890    Fax: 770-997-7894

Mary Katherine Lawless, SLP-CFY Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Upper Riverdale Rd Sw, Riverdale, GA 30274 Phone: 770-991-1050

Ms. Sheredia D. Langhorne Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6930 Cottonwood Trl, Riverdale, GA 30296 Phone: 770-997-8250

Alexis R Marshall Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 Blue Cedar Ct, Riverdale, GA 30274 Phone: 404-660-6549

Brighter Voices Speech And Language Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Derby Dr, Riverdale, GA 30274 Phone: 770-827-0875    Fax: 678-489-7263

Audrey Larcomb, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6572 River Park Dr Ste 101, Riverdale, GA 30274 Phone: 678-262-1833

Patricia Robinson Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 113 Derby Dr, Riverdale, GA 30274 Phone: 404-449-6107

Brighter Voices Speech And Language Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Derby Dr, Riverdale, GA 30274 Phone: 404-246-2297

Outspoken Therapy Services , Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6788 Church St, Riverdale, GA 30274 Phone: 770-907-8061

Mr. Michael Andrew Taylor, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 836 Verde Dr, Riverdale, GA 30274 Phone: 770-909-1361

Mrs. Wendy Seay Oliver, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 812 Verde Dr, Riverdale, GA 30274 Phone: 770-907-8061    Fax: 770-909-9912

News Archive

Expanding quantum dot utility in cancer diagnosis and treatment

Quantum dots (QDs), nanoparticles that shine with extraordinary brightness when excited by light energy, have shown promise as new tools for detecting cancer at its earliest appearance, but concerns about potential toxicities have limited their clinical development. Researchers at the University of Buffalo may have found an answer to this limitation with their development of a new way to create QDs.

Scientists receive $12.5M NIH grant to continue research on targeted therapies for melanoma

Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.

OCD diagnosis raises risk of subsequent schizophrenia

Patients who are diagnosed with obsessive–compulsive disorder are at increased risk of developing schizophrenia and schizophrenia spectrum disorders, a longitudinal study reports.

Transcept announces Intermezzo tablet preliminary data for insomnia

Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.

Read more Medical News

› Verified 6 days ago